Paul Rosie joined Goodwin as a partner in its life sciences group in Boston, the firm announced Tuesday.
Rosie advises high-growth companies and investors across the full corporate lifecycle, including venture capital financings, mergers and acquisitions, and capital markets transactions. He represents startups through later-stage companies, as well as venture capital funds, with a focus on the life sciences and technology industries, the firm said.
Rosie was most recently at Morse, according to his LinkedIn profile.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.